Funded Tech Companies

Kymera Therapeutics

Kymera Therapeutics, based in Cambridge, received equity investments from BVF Partners, BlackRock and Wellington Management Company.

Company Overview

Contact Information

Company Background Information

Overview

Kymera Therapeutics (Nasdaq: KYMR). Despite recent advances in modern medicine, hundreds of millions of people are affected by acute and chronic diseases with limited or no available treatment options. Kymera is pioneering a game-changing new therapeutic modality with the potential to transform drug discovery and provide breakthrough treatments for previously untreatable diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/20/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Nello Mainolfi

        

Chief Financial Officer

Bruce Jacobs

        

Chief Medical Officer

Jared Gollob

        

Company Investors

• BVF Partners
• BlackRock
• Wellington Management Company
• Rock Springs Capital
• Bain Capital Life Sciences
• Redmile Group
• Janus Henderson Investors
• The Leukemia & Lymphoma Society
• Pfizer Venture Investments
• Sanofi-Genzyme BioVentures
• 6 Dimensions Capital
• Hatteras Venture Partners
• Bessemer Venture Partners
• MRL Ventures
• AJU IB Investment
• Amgen Ventures
• Lilly Ventures (Steve Hall)
• Atlas Venture (Bruce Booth)

Browse more funded tech companies:

Kymab | Kymeta

Share this article

About Our VC Transaction Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary